Beyond supporting its VitaSmart system's US rollout, Bridge to Life also intends to use the funds to expand its portfolio and scale its global operations.

Zepto's grant from NIAID follows its fungal infection panel's receipt of breakthrough device designation from the FDA in June 2026.

Abbott and Google Health have collaborated to bring ongoing glucose monitoring and AI-driven health guidance to Google Health users.

Teledyne Technologies has entered a definitive agreement to purchase Varex Imaging in a cash transaction valued at nearly $1.1bn.

The lion’s share of Alcon’s profits came from its surgical segment at around $1.6bn, indicative of an 8% uptick YoY.

Integer Holdings is to be acquired by an affiliate of investment funds managed by KKR, in an all-cash deal valuing the company at $5.7bn.

Acarix has secured regulatory approval for its CADScor system in the UAE, a step that paves the way for the device's commercial availability.

GlobalData analysts Dr Andrew Thompson and Charlie Whelan will discuss key challenges impacting the diabetes technology supply chain in a webinar on 18 August.

Collette Health has entered into a partnership with VirtuAlly to provide virtual care programmes for hospitals and health systems.

Resmed highlighted that factors including suspended ventilator sales and ongoing macro uncertainty had contributed to its tempered FY27 outlook.

BlueWind Medical’s Revi Extend, the company’s next-generation urge urinary incontinence (UUI) treatment that extends the implant’s lifespan to 15 years, has secured US Food ...

Azra AI and Blackford have formed a partnership to support the progression from imaging-based detection to care coordination for patients with complex or urgent health conditions.